Cbl-b and c-Cbl negatively regulate osteoblast differentiation by enhancing ubiquitination and degradation of Osterix

Bone

Volumn 75, Issue , 2015, Pages 201-209

  Choi, You Hee ^a   Han, Younho ^a   Lee, Sung Ho ^a   Jin, Yun Hye ^a   Bahn, Minjin ^b   Hur, Kyu Chung ^b   Yeo, Chang Yeol ^b   Lee, Kwang Youl ^a  

^a Chonnam National University   (South Korea)

^b Ewha Womans University   (South Korea)

Author keywords

Cbl; Osteoblast differentiation; Osterix; Ubiquitination

Indexed keywords

CBL PROTEIN; PROTEIN CBL B; TRANSCRIPTION FACTOR OSTERIX; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; CBLB PROTEIN, MOUSE; OSTERIX PROTEIN, MOUSE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INHIBITION KINETICS; MESENCHYME CELL; MOUSE; NONHUMAN; OSTEOBLAST; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN TARGETING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UBIQUITINATION; ANIMAL; BONE DEVELOPMENT; CELL LINE; CYTOLOGY; GENETIC TRANSFECTION; IMMUNOBLOTTING; IMMUNOPRECIPITATION; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL DIFFERENTIATION; CELL LINE; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MICE; OSTEOBLASTS; OSTEOGENESIS; PROTO-ONCOGENE PROTEINS C-CBL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TRANSFECTION; UBIQUITINATION;

EID: 84924702605     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2015.02.026     Document Type: Article

References (52)

1. Katagiri T., Takahashi N. Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis 2002, 8:147-159.
2. Heino T.J., Hentunen T.A. Differentiation of osteoblasts and osteocytes from mesenchymal stem cells. Curr Stem Cell Res Ther 2008, 3:131-145.
3. Kawamura N., Kugimiya F., Oshima Y., Ohba S., Ikeda T., Saito T., et al. Akt1 in osteoblasts and osteoclasts controls bone remodeling. PLoS One 2007, 2:e1058.
4. Blum B., Moseley J., Miller L., Richelsoph K., Haggard W. Measurement of bone morphogenetic proteins and other growth factors in demineralized bone matrix. Orthopedics 2004, 27:s161-s165.
5. Yamaguchi A., Komori T., Suda T. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr Rev 2000, 21:393-411.
6. Ohba S., Chung U.I., Tei Y. Osteoblast differentiation induced by BMP signaling and Runx2 through Cbfb regulation. Nihon Rinsho 2007, 65(Suppl. 9):71-74.
7. Matsubara T., Kida K., Yamaguchi A., Hata K., Ichida F., Meguro H., et al. BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation. J Biol Chem 2008, 283:29119-29125.
8. Ulsamer A., Ortuno M.J., Ruiz S., Susperregui A.R., Osses N., Rosa J.L., et al. BMP-2 induces Osterix expression through up-regulation of Dlx5 and its phosphorylation by p38. J Biol Chem 2008, 283:3816-3826.
9. Komori T. Regulation of osteoblast differentiation by transcription factors. J Cell Biochem 2006, 99:1233-1239.
10. Lee M.H., Kwon T.G., Park H.S., Wozney J.M., Ryoo H.M. BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochem Biophys Res Commun 2003, 309:689-694.
11. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997, 89:755-764.
12. Bendall A.J., Abate-Shen C. Roles for Msx and Dlx homeoproteins in vertebrate development. Gene 2000, 247:17-31.
13. Hassan M.Q., Javed A., Morasso M.I., Karlin J., Montecino M., van Wijnen A.J., et al. Dlx3 transcriptional regulation of osteoblast differentiation: temporal recruitment of Msx2, Dlx3, and Dlx5 homeodomain proteins to chromatin of the osteocalcin gene. Mol. Cell. Biol. 2004, 24:9248-9261.
14. Nakashima K., Zhou X., Kunkel G., Zhang Z., Deng J.M., Behringer R.R., et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002, 108:17-29.
15. Li H., Marijanovic I., Kronenberg M.S., Erceg I., Stover M.L., Velonis D., et al. Expression and function of Dlx genes in the osteoblast lineage. Dev Biol 2008, 316:458-470.
16. Fu H., Doll B., McNelis T., Hollinger J.O. Osteoblast differentiation in vitro and in vivo promoted by Osterix. J Biomed Mater Res A 2007, 83:770-778.
17. Tu Q., Valverde P., Chen J. Osterix enhances proliferation and osteogenic potential of bone marrow stromal cells. Biochem Biophys Res Commun 2006, 341:1257-1265.
18. Kim Y.J., Kim H.N., Park E.K., Lee B.H., Ryoo H.M., Kim S.Y., et al. The bone-related Zn finger transcription factor Osterix promotes proliferation of mesenchymal cells. Gene 2006, 366:145-151.
19. Hatta M., Yoshimura Y., Deyama Y., Fukamizu A., Suzuki K. Molecular characterization of the zinc finger transcription factor, Osterix. Int J Mol Med 2006, 17:425-430.
20. Zhang C., Cho K., Huang Y., Lyons J.P., Zhou X., Sinha K., et al. Inhibition of Wnt signaling by the osteoblast-specific transcription factor Osterix. Proc Natl Acad Sci U S A 2008, 105:6936-6941.
21. Kaabeche K., Lemonnier J., Le Mee S., Caverzasio J., Marie P.J. Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation. J Biol Chem 2004, 279:36259-36267.
22. Severe N., Miraoui H., Marie P.J. The Casitas B lineage lymphoma (Cbl) mutant G306E enhances osteogenic differentiation in human mesenchymal stromal cells in part by decreased Cbl-mediated platelet-derived growth factor receptor alpha and fibroblast growth factor receptor 2 ubiquitination. J Biol Chem 2011, 286:24443-24450.
23. Brennan T., Adapala N.S., Barbe M.F., Yingling V., Sanjay A. Abrogation of Cbl-PI3K interaction increases bone formation and osteoblast proliferation. Calcif Tissue Int 2011, 89:396-410.
24. Guenou H., Kaabeche K., Dufour C., Miraoui H., Marie P.J. Down-regulation of ubiquitin ligase Cbl induced by twist haploinsufficiency in Saethre-Chotzen syndrome results in increased PI3K/Akt signaling and osteoblast proliferation. Am J Pathol 2006, 169:1303-1311.
25. Dieudonne F.X., Severe N., Biosse-Duplan M., Weng J.J., Su Y., Marie P.J. Promotion of osteoblast differentiation in mesenchymal cells through Cbl-mediated control of STAT5 activity. Stem Cells 2013, 31:1340-1349.
26. Suzue N., Nikawa T., Onishi Y., Yamada C., Hirasaka K., Ogawa T., et al. Ubiquitin ligase Cbl-b downregulates bone formation through suppression of IGF-I signaling in osteoblasts during denervation. J Bone Miner Res 2006, 21:722-734.
27. Adapala N.S., Barbe M.F., Langdon W.Y., Nakamura M.C., Tsygankov A.Y., Sanjay A. The loss of Cbl-phosphatidylinositol 3-kinase interaction perturbs RANKL-mediated signaling, inhibiting bone resorption and promoting osteoclast survival. J Biol Chem 2010, 285:36745-36758.
28. Nakajima A., Sanjay A., Chiusaroli R., Adapala N.S., Neff L., Itzsteink C., et al. Loss of Cbl-b increases osteoclast bone-resorbing activity and induces osteopenia. J Bone Miner Res 2009, 24:1162-1172.
29. Lupher M.L., Rao N., Eck M.J., Band H. The Cbl protooncoprotein: a negative regulator of immune receptor signal transduction. Immunol Today 1999, 20:375-382.
30. Thien C.B., Langdon W.Y. Cbl: many adaptations to regulate protein tyrosine kinases. Nat Rev Mol Cell Biol 2001, 2:294-307.
31. Thien C.B., Langdon W.Y. c-Cbl and Cbl-b ubiquitin ligases: substrate diversity and the negative regulation of signalling responses. Biochem J 2005, 391:153-166.
32. Severe N., Dieudonne F.X., Marie P.J. E3 ubiquitin ligase-mediated regulation of bone formation and tumorigenesis. Cell Death Dis 2013, 4:e463.
33. Thien C.B., Langdon W.Y. Negative regulation of PTK signalling by Cbl proteins. Growth Factors 2005, 23:161-167.
34. Sasaki A., Masuda Y., Iwai K., Ikeda K., Watanabe K. A RING finger protein Praja1 regulates Dlx5-dependent transcription through its ubiquitin ligase activity for the Dlx/Msx-interacting MAGE/Necdin family protein, Dlxin-1. J Biol Chem 2002, 277:22541-22546.
35. Salingcarnboriboon R.A., Pavasant P., Noda M. Cbl-b enhances Runx2 protein stability and augments osteocalcin promoter activity in osteoblastic cell lines. J Cell Physiol 2010, 224:743-747.
36. von Kampen J., Wettern M. Ubiquitin-dependent degradation and modification of proteins. Naturwissenschaften 1992, 79:163-170.
37. Yokouchi M., Kondo T., Sanjay A., Houghton A., Yoshimura A., Komiya S., et al. Src-catalyzed phosphorylation of c-Cbl leads to the interdependent ubiquitination of both proteins. J Biol Chem 2001, 276:35185-35193.
38. Lupher M.L., Rao N., Lill N.L., Andoniou C.E., Miyake S., Clark E.A., et al. Cbl-mediated negative regulation of the Syk tyrosine kinase. A critical role for Cbl phosphotyrosine-binding domain binding to Syk phosphotyrosine 323. J Biol Chem 1998, 273:35273-35281.
39. Rao N., Miyake S., Reddi A.L., Douillard P., Ghosh A.K., Dodge I.L., et al. Negative regulation of Lck by Cbl ubiquitin ligase. Proc Natl Acad Sci U S A 2002, 99:3794-3799.
40. Tsygankov A.Y., Teckchandani A.M., Feshchenko E.A., Swaminathan G. Beyond the RING: CBL proteins as multivalent adapters. Oncogene 2001, 20:6382-6402.
41. Dufour C., Guenou H., Kaabeche K., Bouvard D., Sanjay A., Marie P.J. FGFR2-Cbl interaction in lipid rafts triggers attenuation of PI3K/Akt signaling and osteoblast survival. Bone 2008, 42:1032-1039.
42. Severe N., Dieudonne F.X., Marie P.J. E3 ubiquitin ligase-mediated regulation of bone formation and tumorigenesis. Cell Death Dis 2013, 4.
43. Soriano P., Montgomery C., Geske R., Bradley A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 1991, 64:693-702.
44. Rao N., Ghosh A.K., Douillard P., Andoniou C.E., Zhou P., Band H. An essential role of ubiquitination in Cbl-mediated negative regulation of the Src-family kinase Fyn. Signal Transduct 2002, 2:29-39.
45. Horne W.C., Sanjay A., Bruzzaniti A., Baron R. The role(s) of Src kinase and Cbl proteins in the regulation of osteoclast differentiation and function. Immunol Rev 2005, 208:106-125.
46. Kim J.H., Kim K., Jin H.M., Song I., Youn B.U., Lee S.H., et al. Negative feedback control of osteoclast formation through ubiquitin-mediated down-regulation of NFATc1. J Biol Chem 2010, 285:5224-5231.
47. Hakak Y., Martin G.S. Ubiquitin-dependent degradation of active Src. Curr Biol 1999, 9:1039-1042.
48. Hakak Y., Martin G.S. Cas mediates transcriptional activation of the serum response element by Src. Mol. Cell. Biol. 1999, 19:6953-6962.
49. Sanjay A., Houghton A., Neff L., DiDomenico E., Bardelay C., Antoine E., et al. Cbl associates with Pyk2 and Src to regulate Src kinase activity, alpha(v)beta(3) integrin-mediated signaling, cell adhesion, and osteoclast motility. J Cell Biol 2001, 152:181-195.
50. Tanaka S., Neff L., Baron R., Levy J.B. Tyrosine phosphorylation and translocation of the c-cbl protein after activation of tyrosine kinase signaling pathways. J Biol Chem 1995, 270:14347-14351.
51. Kassenbrock C.K., Hunter S., Garl P., Johnson G.L., Anderson S.M. Inhibition of Src family kinases blocks epidermal growth factor (EGF)-induced activation of Akt, phosphorylation of c-Cbl, and ubiquitination of the EGF receptor. J Biol Chem 2002, 277:24967-24975.
52. Severe N., Dieudonne F.X., Marty C., Modrowski D., Patino-Garcia A., Lecanda F., et al. Targeting the E3 ubiquitin casitas B-lineage lymphoma decreases osteosarcoma cell growth and survival and reduces tumorigenesis. J Bone Miner Res 2012, 27:2108-2117.